Optima Capital’s Exelixis EXEL Stock Holding History

Optima Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-62	Closed	-$2.72K	–	532
2025 Q4	$2.72K	Buy	+62	New	+$2.56K	﹤0.01%	717

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Optima Capital's EXEL Position: Q1 2026 in Review

Optima Capital sold out of Exelixis (EXEL) in Q1 2026, closing a stake of 62 shares — an estimated $2.72K sold.

Optima Capital first reported a position in EXEL in Q4 2025 and held it in 1 quarter. The position peaked at $2.72K in Q4 2025. 701 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

Optima Capital reported no remaining Exelixis position as of Q1 2026 after selling out during the quarter.
Optima Capital sold 62 Exelixis shares in Q1 2026, an estimated $2.72K.
Optima Capital first reported a position in Exelixis in Q4 2025 and held it in 1 quarter.
Optima Capital's Exelixis position peaked at $2.72K in Q4 2025.
701 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Optima Capital's 13F filing for Q1 2026, filed 5 May 2026.